TMCnet News

Entellus Medical, Inc. Files Registration Statement for Proposed Initial Public Offering
[December 23, 2014]

Entellus Medical, Inc. Files Registration Statement for Proposed Initial Public Offering


Entellus Medical, Inc., a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC (News - Alert)) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Entellus Medical. The number of shares to be offered and the price range for the offering have not yet been determined.

BofA Merrill Lynch and Piper Jaffray are acting as joint book-running managers for the offering. William Blair and Canaccord Genuity are acting as co-managers. The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus describing the offering may be obtained by contacting BofA Merrill Lynch at 222 Broadway, New York, NY 10038, Attention: Prospectus Department or by e-mail at [email protected] or Piper Jaffray at 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, Attention: Equity Capital Markets, by telephone at 800-747-3924 or by e-mail at [email protected].



A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Entellus Medical


Entellus Medical is a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room. Its XprESS family of products is used by ENT physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation. When used as a stand-alone therapy, Entellus Medical's balloon sinus dilation products are the only devices proven in a sufficiently powered prospective, multicenter, randomized, controlled trial to be as effective as functional endoscopic sinus surgery, or FESS. Patients treated with Entellus Medical's products in this trial in the ENT physician office also experienced faster recovery, less bleeding at discharge, less use of prescription pain medication and fewer post-procedure debridements than patients receiving FESS. Entellus Medical currently markets its products in the United States and Canada and sells its products through a direct sales force in the United States.


[ Back To TMCnet.com's Homepage ]